These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2062607)

  • 21. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
    Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
    J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.
    Lang DR; Allos BM; Blaser MJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S198-200. PubMed ID: 9396711
    [No Abstract]   [Full Text] [Related]  

  • 24. The changing concepts of Guillain-Barré syndrome.
    Bolton CF
    N Engl J Med; 1995 Nov; 333(21):1415-7. PubMed ID: 7477125
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guillain-Barré syndrome preceded by diarrhea with the infection of Campylobacter jejuni].
    Yamada S; Bandoh M; Nagura H; Yamanouchi H; Inamatsu T
    Rinsho Shinkeigaku; 1991 Aug; 31(8):882-4. PubMed ID: 1764866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
    [No Abstract]   [Full Text] [Related]  

  • 28. Campylobacter infections, Guillain-Barré syndrome, and parenteral gangliosides.
    Callegaro L; Jack DB; Samson JC
    Lancet; 1991 Mar; 337(8744):789. PubMed ID: 1672406
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe Guillain-Barré syndrome associated with Campylobacter jejuni infection with failure to respond to plasmapheresis and immunoglobulin.
    Allen A; Antony SJ
    J Am Board Fam Pract; 1999; 12(3):249-52. PubMed ID: 10395423
    [No Abstract]   [Full Text] [Related]  

  • 30. [Etiological mechanism and treatment of Guillain-Barre syndrome-- Campylobacter jejuni enteritis and the development of anti-ganglioside antibody preceding the syndrome].
    Yuki N
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):612-6. PubMed ID: 9627467
    [No Abstract]   [Full Text] [Related]  

  • 31. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Five cases of Campylobacter jejuni enteritis accompanied with Guillain-Barré syndrome].
    Yuan JM; Tang J; Hao HJ
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):375-7. PubMed ID: 8269767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of Guillain-Barré syndrome after the travel in southeast Asia--isolation of Campylobacter jejuni PEN 5 serotype].
    Koide T; Yamazaki M; Onishi Y; Saito K; Yuki N
    Rinsho Shinkeigaku; 1997 Jan; 37(1):41-3. PubMed ID: 9146072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
    Li H; Yuan J; Shen B; Sun X; Hao H
    Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.
    Kuroki S; Saida T; Nukina M; Haruta T; Yoshioka M; Kobayashi Y; Nakanishi H
    Ann Neurol; 1993 Mar; 33(3):243-7. PubMed ID: 8498807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
    Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
    Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guillain-Barré syndrome following Campylobacter jejuni enteritis].
    Beenen LF; Scholten HG
    Ned Tijdschr Geneeskd; 1990 May; 134(20):1010-2. PubMed ID: 2348889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
    Takahashi M; Koga M; Yokoyama K; Yuki N
    J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome.
    Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K
    Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.